Among the top pathways, including 31 activated in at least four tumor types, we observed a strong impact of CTNNB1 as well as several other pathways described in the literature as influencing anti-tumor immunity such as MYC [55], PPARG [56] and SHH (sonic hedgehog) [57]. This evidence concerns the gene CTNNB1 and neoplasm.